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The practice of Ayurveda, the traditional medicine of India, is based on the concept of three major 
constitutional types (Vata, Pitta and Kapha) defined as “Prakriti”. To the best of our knowledge, no 
study has convincingly correlated genomic variations with the classification of Prakriti. In the present 
study, we performed genome-wide SNP (single nucleotide polymorphism) analysis (Affymetrix, 6.0) 
of 262 well-classified male individuals (after screening 3416 subjects) belonging to three Prakritis. We 
found 52 SNPs (p ≤ 1 × 10−5) were significantly different between Prakritis, without any confounding 
effect of stratification, after 106 permutations. Principal component analysis (PCA) of these SNPs 
classified 262 individuals into their respective groups (Vata, Pitta and Kapha) irrespective of their 
ancestry, which represent its power in categorization. We further validated our finding with 297 
Indian population samples with known ancestry. Subsequently, we found that PGM1 correlates 
with phenotype of Pitta as described in the ancient text of Caraka Samhita, suggesting that the 
phenotypic classification of India’s traditional medicine has a genetic basis; and its Prakriti-based 
practice in vogue for many centuries resonates with personalized medicine.
Among the traditional systems of medicine practiced all over the world, Ayurveda of India has a docu-
mented history dating back to 1500 BCE1,2. Though contemporary medicine is currently the mainstream 
of medical practice in India, Ayurveda is extensively used side by side and remains highly popular, 
especially in South Asia. The basic concepts of Ayurveda are; 1. five elements – panchabhuta – which 
constitute the physical universe including the human body and; 2. three doshas (Vata, Pitta and Kapha) 
or constitutional types of every human. These doshas refer broadly to the functions of motion, digestion 
and cumulation. Though all three doshas exist in every human being one is dominant based on which 
an individual’s Prakriti is determined. Prakritis are discreet phenotypes and they are determined on the 
basis of physical, psychological, physiological and behavioural traits, and independent of social, ethnic 
and geographical variables1,3,4. The etymology of these Sanskrit terms suggests that Vata originates from 
movement, Pitta from digestion and Kapha from cumulation. Since Prakritis underlie an individual’s 
predisposition to disease as well as response to treatment, it is imperative in Ayurvedic practice to identify 
the Prakriti of a patient before treatment5.
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Concept of Prakriti in Ayurveda and its relationship with genomics was hypothesized over a decade 
ago6. Subsequent studies have attempted to correlate Prakriti classification with genetic information and 
association of single nucleotide polymorphisms (SNPs) in HLA-DRB17, CYP2C198, EGLN19, inflamma-
tory and oxidative stress related genes10, CD markers for various blood cells11,12, DNA methylation alter-
ations13 and risk factors of cardiovascular or inflammatory diseases have been reported14. While these 
studies have shown the association of specific genes with the phenotype of a particular Prakriti, the asso-
ciation of genomic variations with Prakriti classification was lacking. This is the first attempt to classify 
the Prakritis using genome-wide SNP markers and to provide a scientific basis for Prakriti classification.
Results and Discussions
A total of 3,416 normal healthy male subjects between 20–30 years of age were recruited by the Institute 
of Ayurveda and Integrative Medicine (IAIM), Bangalore, Karnataka (‘B’ in tables); Sinhgad College 
of Engineering (SCE) Pune, Maharashtra (‘P’ in tables); and Shri Dharmasthala Manjunatheshwara 
College of Ayurveda (SDMCA), Udupi, Karnataka (‘U’ in tables). Since the hormonal fluctuations dur-
ing premenstrual and menstrual phases result in numerous physical and psychological disturbances, 
which may have confounding effect at the time of Prakriti assessment, we have excluded females from 
this study (detailed justification on inclusion of only males is given in the Methods section). However, 
several studies have included of both male and female subjects for Ayurveda-based studies7,8,15,16. The 
subjects belonged to diverse ethnic and linguistic groups, and inhabited different geographical regions. 
The health status of every individual was ascertained by modern as well as Ayurvedic methods (details 
given in the Methods). The composition of Prakriti was determined by senior Ayurvedic physicians and 
confirmed independently by ‘AyuSoft’ (http://ayusoft.cdac.in), a software developed based on informa-
tion from classical Ayurvedic literature. The subjects, whose Prakriti was in concordance between the 
assessment by Ayurvedic physicians and by AyuSoft were only selected for this study. Of the total 3,416 
individuals evaluated, 971 had 60%–93% dominance of one Prakriti (Table S1), of which 262 individuals 
(94 Vata-dominant, 75 Pitta-dominant and 93 Kapha-dominant) with the highest proportion of one 
predominant Prakriti were randomly selected and subjected to genome-wide SNP analysis (Affymetrix 
array, 6.0) and genotypes were fetched using Birdsuite software17. The proportions of each dominant and 
co-dominant Prakritis are given in Fig. 1; Figure S1.
Out of 262 individuals analyzed, 245 passed the quality controls (QC) with the call rate 0.966 ± 0.0162 
(Table S2). In order to validate the high-throughput data set, we randomly selected 48 markers 
from Affymetrix array and genotyped 48 individuals using custom-designed VeraCode GoldenGate 
Genotyping Assay System (Illumina, San Diego, USA). The call rate of VeraCode analysis was 99.61% and 
the genotype matched with Affymetrix data set (Table S3), suggesting that the genotypes obtained from 
Affymetrix array was genuine with minimum error (0.39%). Further, to increase the statistical power, we 
used Indian population data set as reference and imputation analysis was performed using Beagle (v3.3.1) 
software18 (Figure S1). As we had demonstrated earlier that Indian population has unique genetic archi-
tecture, we were skeptical of using non-Indian samples as a reference for imputation19. To evaluate our 
assumption, we masked 2%, 5% and 10% genotype of 207 unrelated Dravidian and Indo-European pop-
ulation samples and performed 110 simulations on chromosome 22 with four-reference populations i.e. 
Indian population (28 trios of Dravidian and Indo-Europeans; IN), different HapMap populations (CEU, 
YRI, CHB, CHS and JPT; HM), different South-Asian populations of 1000 genome project (BEB, GIH, 
ITU, PJL and STU; SA) and Indian along with HapMap populations (IH). As expected, imputed geno-
types were more accurate with Indian samples (IN) [2% (0.9518 ± 0.0012); 5% (0.95045 ± 0.00109); 10% 
(0.9476 ± 0.0005)] compared to HM [2% (0.9462 ± 0.0013); 5% (0.9436 ± 0.0017); 10% (0.9396 ± 0.0005)], 
IH [2% (0.9463 ± 0.0014); 5% (0.9448 ± 0.0016); 10% (0.9417 ± 0.00066)] and SA [2% (0.9481 ± 0.0013); 
5% (0.9471 ± 0.00098); 10% (0.9441 ± 0.00061)] samples (Table S4; Figure S2). In all the three masked 
data (2%, 5% and 10%), IN showed high imputation performance compared to HM, SA and IH. Even 
with ~10% masked data, the imputed genotypes were more accurate with IN than other references, 
suggesting that it is appropriate to use Indian data set for imputation. The data set of Gujarati Indians in 
Houston (GIH) is the only one available in the public domain, which was admixed recently, and hence 
does not truly represent the ANI-ASI ancestry of Indian population19,20. As the data were not suitable 
reference for imputation, we prepared our own reference panel of Indian population (http://www.ccmb.
res.in/bic/database_pagelink.php?page=snpdata). To achieve this, we followed two steps (i) imputation 
of 15 trios of Indo-European and 15 trios of Dravidian, and (ii) imputation of 229 unrelated individuals 
imputed with the reference genotype obtained from step-I. Further, we used this reference for imputing 
the Prakriti individuals. In the first step, we found 10.5% and 17.8% Mendelian inconsistency in two 
trios, (Kashmiri Pandit) (Table S5), which were removed from the analysis. Finally, we obtained 791186 
SNP markers with 0.95 ≤ R2 ≤ 1, for further analysis.
To make sure that the Prakriti samples were collected randomly and there was no major ancestral bias 
while collecting samples, we performed the principal component analysis (PCA)21 of 245 Prakriti sam-
ples (Figure S3). PCA analysis revealed no significant overall differences among the Prakritis (ANOVA 
p-value on eigenvector 1 V vs. K-0.434; V vs. P-0.89; P vs. K-0.51; and eigenvector 2 V vs. K-0.09; V 
vs. P-0.06; P vs. K-0.02). In order to check the ancestry of Prakriti individuals, we used our published 
data set of 297 Indian population samples with known ancestry19,20. These 297 samples include; 150 
Dravidians, 80 Indo-European, 35 Austro-Asiatic, 27 Tibeto-Burman and 5 Great Andamanese (Table 
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S6). We found 7,89,309 SNPs were common between Prakriti and Indian ancestral samples. In order to 
remove the differentiation on spurious axes21, we pruned 3,76,138 SNPs, which were in strong linkage 
disequilibrium (LD) (r2 > 0.75), and performed PCA with 4,13,171 SNPs. Our analysis showed that most 
of the Prakriti samples clustered with Dravidian and Indo-European (the two major ancestral population 
of India), and only 3 samples seemed to be Tibeto-Burman and admixed recently (Figure S4). Previous 
studies have shown that stratification could cause spurious association22–25, hence, PCA was performed21 
using 4,05,782 SNPs (3,85,404 SNPs were pruned with r2 > 0.75) for 245 Prakriti samples, of which 40 
were outliers and have been removed in 10 iterations with σ ≥ 6 on eigenvector 1 to 10 (Table S7; Figure 
S3 and S5). ANOVA analysis revealed that the Prakriti groups were not significantly different (p-value: 
V vs. P - 0.40 ± 0.28; V vs. K - 0.51 ± 0.32 and P vs. K - 0.48 ± 0.29) (Table S8); and 205 Prakriti samples 
were used for further analysis (Figure S1).
Association analysis was performed using plink software26. Since the present study has no cases and 
controls (patients and healthy), we considered one Prakriti as case and the remaining two Prakritis as 
controls, and performed association analyses in three combinations: Vata vs. Kapha and Pitta (V vs. PK); 
Pitta vs. Kapha and Vata (P vs. VK); Kapha vs. Pitta and Vata (K vs. VP). Prior to association analysis, 
3,890; 4,153 and 4,124, respectively, markers were removed from 791186 markers, which were not in 
Hardy-Weinberg equilibrium (HWE) i.e. p-value < 0.001 in controls of V vs. PK, P vs. VK and K vs. VP; 
respectively. The three combination association results were further used to identify the SNPs that were 
significant. Considering the fact that none of the samples represents 100% single Prakriti, we did not 
expect very low p-value in the association analysis. In this scenario, truly associated loci may co-exist 
with false positive markers and can be identified by permutation analysis. As expected, we observed that 
SNPs having approximately same p-value in the extreme tail of theoretical distribution failed to achieve 
106 permutations (Table  1). For example, rs2939743 having p-value 7.61 × 10−5 dropped at 142717th 
Figure 1. Box-plot representing the Prakriti proportion of subjects with Vata (94), Pitta (75) and Kapha 
(93) dominant characteristics. (A) Average percentage of Vata is 67%, while Pita and Kapha are 12% 
and 18.5%, respectively. (B) Average percentage of Pita is 65%, while Vata and Kapha are 12% and 17%, 
respectively. (C) Average percentage of Kapha is 70%, while Vata and Pita are 12% and 17%, respectively.
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Chr rsIDs Gene
Position 
(hg19)
Minor 
allele
Theoretical distribution Empirical distribution
MAF 
Prakriti I
MAF 
Prakriti 
II + III
Major 
allele
Chi-
square P-value
ODD- 
ratio P-value
No. of 
permuta-
tion
Passed in 
permuta-
tion
Vata
2 rs10197747 – 57644785 C 0.06875 0 A 17.66 2.64E–05 NA 2.50E–05 1000000 Passed
3 rs10446349 VPS8 186131720 G 0.6 0.4 A 15.64 7.66E–05 2.25 2.40E–05 1000000 Passed
1 rs10489167 NFYC 40949053 A 0.15 0.036 G 17.13 3.49E–05 4.725 6.57E–05 639360 –
15 rs10518915 CGNL1 55472117 C 0.6062 0.372 A 21.53 3.49E–06 2.599 4.00E–06 1000000 Passed
5 rs10866665 – 172908297 G 0.325 0.54 A 18.18 2.01E–05 0.4102 3.90E–05 1000000 Passed
10 rs10882293 PDE6C 95401687 T 0.6188 0.416 C 16.04 6.19E–05 2.278 6.60E–05 636363 –
5 rs11134808 – 172909959 G 0.325 0.536 A 17.52 2.84E–05 0.4168 4.55E–05 924075 –
7 rs11768155 SEMA3C 80203792 C 0.1062 0.016 T 16.35 5.26E–05 7.311 8.56E–05 490509 –
10 rs11815547 – 13647633 T 0.1688 0.044 A 18.06 2.15E–05 4.411 8.19E–05 513000 –
2 rs11902715 FIGN 164190114 G 0.2062 0.068 A 17.41 3.01E–05 3.561 3.60E–05 1000000 Passed
10 rs12266365 PDE6C 95398869 C 0.6188 0.416 A 16.04 6.19E–05 2.278 6.60E–05 636363 –
2 rs12473563 – 226605892 G 0.2375 0.452 A 19.29 1.12E–05 0.3776 6.48E–05 648351 –
6 rs12526892 PACRG, PACRG–AS1 163641063 A 0.15 0.344 G 18.7 1.53E–05 0.3365 6.00E–06 1000000 Passed
10 rs12781996 – 108025031 A 0.1 0.26 G 15.75 7.21E–05 0.3162 3.10E–05 1000000 Passed
2 rs13006806 – 226606872 C 0.2375 0.452 G 19.29 1.12E–05 0.3776 6.48E–05 648351 –
10 rs1326217 PDE6C 95400989 T 0.6188 0.404 A 18.01 2.20E–05 2.394 3.10E–05 1000000 Passed
8 rs13273017 RIMS2 104994931 T 0.4875 0.288 C 16.74 4.30E–05 2.352 7.83E–05 549450 –
2 rs13396046 – 57707740 A 0.06875 0 G 17.66 2.64E–05 NA 2.50E–05 1000000 Passed
2 rs1376616 – 79479938 C 0.1 0.012 T 17.1 3.56E–05 9.148 3.60E–05 1000000 Passed
11 rs1439528 – 96115783 A 0.625 0.408 G 18.38 1.81E–05 2.418 1.20E–05 1000000 Passed
2 rs1440472 FIGN 164193843 T 0.2625 0.108 C 16.64 4.52E–05 2.94 2.60E–05 1000000 Passed
15 rs1664454 CGNL1 55469925 T 0.5188 0.288 C 22.09 2.60E–06 2.665 5.00E–06 1000000 Passed
8 rs1845928 RIMS2 104977275 C 0.4875 0.288 T 16.74 4.30E–05 2.352 7.83E–05 549450 –
7 rs1949971 SEMA3C 80212278 A 0.1062 0.016 G 16.35 5.26E–05 7.311 8.56E–05 490509 –
1 rs2744803 NFYC 40955692 T 0.15 0.036 C 17.13 3.49E–05 4.725 6.57E–05 639360 –
21 rs2825953 – 20315181 A 0.3312 0.152 G 18.15 2.04E–05 2.763 5.67E–05 741000 –
10 rs2901714 PDE6C 95399009 A 0.6125 0.4 T 17.64 2.67E–05 2.371 2.50E–05 1000000 Passed
4 rs2939743 C4orf19 37219957 A 0.5375 0.34 G 15.65 7.61E–05 2.256 0.0002943 142714 –
12 rs3759173 TBX3 113607258 A 0.15 0.032 C 18.88 1.39E–05 5.338 2.30E–05 1000000 Passed
7 rs41486545 SEMA3C 80216538 G 0.1062 0.016 A 16.35 5.26E–05 7.311 8.56E–05 490509 –
8 rs4463386 RIMS2 104955665 A 0.4813 0.288 C 15.75 7.23E–05 2.294 7.83E–05 549450 –
8 rs4467913 RIMS2 105104591 A 0.4437 0.252 G 16.3 5.39E–05 2.368 5.46E–05 770000 –
16 rs4843892 – 84627121 A 0.6 0.4 G 15.64 7.66E–05 2.25 7.99E–05 525474 –
3 rs6443999 VPS8 186056249 C 0.6062 0.404 T 15.98 6.40E–05 2.271 5.96E–05 705294 –
10 rs6583901 PDE6C 95399988 T 0.3438 0.152 C 20.45 6.11E–06 2.922 3.30E–05 1000000 Passed
1 rs6586471 – 104648021 T 0.5125 0.292 C 20.17 7.07E–06 2.549 4.00E–06 1000000 Passed
2 rs6731290 FIGN 164196489 C 0.1812 0.056 T 16.3 5.40E–05 3.732 3.70E–05 1000000 Passed
2 rs6748662 – 57710603 G 0.06875 0 A 17.66 2.64E–05 NA 2.50E–05 1000000 Passed
5 rs7447285 LOC643201 175541987 T 0.075 0.004 C 16.02 6.27E–05 20.19 5.79E–05 726000 –
5 rs7717957 – 172914029 C 0.325 0.54 G 18.18 2.01E–05 0.4102 3.70E–05 1000000 Passed
1 rs823681 NFYC, MIR30C1 41004011 T 0.15 0.036 C 17.13 3.49E–05 4.725 6.57E–05 639360 –
1 rs9438945 RIMS3 40912171 C 0.15 0.036 G 17.13 3.49E–05 4.725 6.57E–05 639360 –
13 rs9547240 LINC00351 84973191 A 0.1875 0.056 G 17.61 2.71E–05 3.89 6.75E–05 622000 –
3 rs9815900 – 45321192 G 0.4062 0.22 C 16.35 5.27E–05 2.426 8.03E–05 523000 –
3 rs9830734 VPS8 186033195 T 0.625 0.408 C 18.38 1.81E–05 2.418 5.00E–06 1000000 Passed
2 rs986846 – 239172751 T 0.5813 0.36 C 19.33 1.10E–05 2.468 1.50E–05 1000000 Passed
Continued
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Pitta
12 rs1005375 – 3307020 T 0.6083 0.3862 C 16.91 3.91E–05 2.468 9.18E–05 457542 –
16 rs10163360 RBFOX1 6622152 A 0.2833 0.1172 G 16.92 3.89E–05 2.977 7.79E–05 539460 –
2 rs10192833 SLC8A1 40480999 C 0.3417 0.1621 T 16.24 5.58E–05 2.683 6.52E–05 644000 –
7 rs10231685 LHFPL3 103963525 G 0.3 0.1207 A 19.06 1.27E–05 3.122 2.00E–05 1000000 Passed
15 rs10518915 CGNL1 55472117 C 0.3 0.531 A 18.22 1.97E–05 0.3785 2.90E–05 1000000 Passed
10 rs10994942 – 63260442 A 0.525 0.3103 G 16.72 4.33E–05 2.456 6.05E–05 694305 –
10 rs10994948 – 63270054 G 0.5 0.2793 A 18.32 1.87E–05 2.58 8.00E–06 1000000 Passed
9 rs11792644 – 121598411 T 0.09167 0.01034 A 17.02 3.70E–05 9.654 9.39E–05 447104 –
16 rs12373036 – 54058839 A 0.4 0.2069 G 16.31 5.37E–05 2.556 0.000101 416000 –
3 rs12490846 PTPRG 61700707 A 0.2667 0.09655 G 19.66 9.24E–06 3.403 8.71E–05 482000 –
13 rs12584835 – 104098930 A 0.325 0.1483 G 16.57 4.69E–05 2.766 8.04E–05 522477 –
7 rs13233643 LHFPL3 103961859 T 0.2917 0.1207 C 17.53 2.84E–05 3 6.12E–05 686313 –
2 rs13423251 NCKAP5 133952350 A 0.3 0.131 G 16.38 5.18E–05 2.842 0.0001232 341000 –
16 rs1558564 RBFOX1 6620427 A 0.35 0.1448 T 21.93 2.82E–06 3.179 4.45E–05 944000 –
3 rs1602754 – 104529406 C 0.1167 0.01724 T 18.99 1.32E–05 7.528 6.79E–05 619000 –
6 rs16890791 LCA5 80244701 C 0.375 0.1828 T 17.25 3.29E–05 2.683 9.71E–05 432567 –
3 rs17065308 PTPRG 61722777 C 0.375 0.1862 T 16.52 4.82E–05 2.622 7.96E–05 527472 –
14 rs17124831 C14orf166 51523799 C 0.4583 0.2483 T 17.52 2.85E–05 2.562 7.83E–05 536463 –
13 rs2209540 – 94437798 G 0.2583 0.09655 T 18.03 2.17E–05 3.259 5.36E–05 783000 –
1 rs2269238 PGM1 63890125 A 0.075 0.2552 C 17.07 3.61E-05 0.2367 3.30E–05 1000000 Passed
1 rs2269239 PGM1 63881947 C 0.075 0.2586 G 17.57 2.77E–05 0.2324 1.90E–05 1000000 Passed
1 rs2269240 PGM1 63881852 G 0.075 0.2586 A 17.57 2.77E–05 0.2324 1.90E–05 1000000 Passed
1 rs2269241 PGM1 63881359 G 0.075 0.2621 A 18.07 2.12E–05 0.2283 2.20E–05 1000000 Passed
15 rs2388017 – 91094840 T 0.2917 0.5276 C 19.03 1.29E–05 0.3687 3.00E–05 1000000 Passed
10 rs2398215 – 10425666 A 0.2667 0.4897 G 17.28 3.23E–05 0.379 7.00E–06 1000000 Passed
6 rs2655668 LCA5 80248839 C 0.45 0.2345 T 18.86 1.41E–05 2.671 1.90E–05 1000000 Passed
6 rs2655670 LCA5 80251062 A 0.3917 0.1966 G 17.07 3.61E–05 2.632 5.81E–05 723000 –
6 rs2655688 – 80316792 G 0.5917 0.3724 C 16.59 4.65E–05 2.442 8.02E–05 524000 –
21 rs2835262 SETD4 36349861 C 0.1333 0.02759 T 17.22 3.32E–05 5.423 0.0001224 343000 –
15 rs2892383 – 91093506 T 0.3 0.5414 C 19.85 8.38E–06 0.3631 2.00E–05 1000000 Passed
5 rs420150 – 141164192 A 0.275 0.1034 C 19.21 1.17E–05 3.287 1.30E–05 1000000 Passed
3 rs4688663 PTPRG 61716091 C 0.3667 0.1793 T 16.61 4.58E–05 2.65 8.08E–05 520000 –
17 rs4789092 RAB37, CD300LF 70203226 C 0.1917 0.05517 A 18.37 1.82E–05 4.061 1.50E–05 1000000 Passed
1 rs619413 HSD52 59394979 T 0.2583 0.4862 G 18.1 2.10E–05 0.3681 1.90E–05 1000000 Passed
2 rs6546604 – 70496311 A 0.4 0.2 G 17.71 2.57E–05 2.667 6.08E–05 691308 –
2 rs6719806 SLC8A1 40512777 C 0.35 0.1655 A 16.86 4.02E–05 2.715 5.05E–05 831000 –
7 rs6969323 LHFPL3 104001723 A 0.3333 0.1483 C 18 2.21E–05 2.872 3.50E–05 1000000 Passed
15 rs7162785 – 91094879 A 0.3167 0.5379 C 16.67 4.45E–05 0.3981 8.28E–05 507492 –
16 rs7200031 RBFOX1 6606974 C 0.3083 0.1345 A 16.99 3.76E–05 2.869 6.77E–05 620000 –
17 rs739354 GAS7 9945013 C 0.1917 0.05862 A 17.06 3.61E–05 3.808 8.59E–05 489000 –
6 rs767789 LCA5 80290087 T 0.5917 0.3655 C 17.69 2.59E–05 2.515 3.70E–05 1000000 Passed
6 rs790607 – 91163700 A 0.3083 0.5276 G 16.41 5.11E–05 0.3992 3.70E–05 1000000 Passed
14 rs8007410 – 55637508 G 0.375 0.1862 T 16.52 4.82E–05 2.622 8.49E–05 494505 –
13 rs9540498 – 33802831 C 0.375 0.1793 G 18 2.21E–05 2.746 7.41E–05 567000 –
Continued
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Kapha
8 rs10086758 – 76924738 T 0.1 0.2929 G 18.55 1.66E–05 0.2683 9.28E–05 452547 –
9 rs10114425 – 110192021 T 0.1846 0.05357 C 17.71 2.57E–05 4 0.000112 375000 –
12 rs10778435 CASC18 104643081 A 0.3077 0.1393 G 16.19 5.74E–05 2.746 8.72E–05 481518 –
12 rs10848194 – 129791290 A 0.2615 0.4893 C 18.94 1.35E–05 0.3697 1.80E–05 1000000 Passed
12 rs10861491 CASC18 104643051 G 0.3077 0.1393 A 16.19 5.74E–05 2.746 8.72E–05 481518 –
1 rs11166345 – 100045548 A 0.2846 0.5107 G 18.43 1.76E–05 0.3812 1.70E–05 1000000 Passed
3 rs11714306 CLSTN2 141227150 C 0.6308 0.4143 T 16.66 4.47E–05 2.415 4.94E–05 850149 –
4 rs11933940 C4orf19 37238765 A 0.2769 0.4893 G 16.42 5.09E–05 0.3998 0.0001007 417000 –
2 rs12473563 – 226605892 G 0.5154 0.3 A 17.7 2.58E–05 2.481 8.75E–05 480000 –
2 rs13006806 – 226606872 C 0.5154 0.3 G 17.7 2.58E–05 2.481 8.75E–05 480000 –
2 rs13429987 – 184201539 G 0.1308 0.3179 A 16.21 5.67E–05 0.3229 3.90E–05 1000000 Passed
2 rs1438266 KYNU 143363789 A 0.4692 0.2643 G 16.88 3.97E–05 2.461 8.58E–05 489510 –
5 rs152270 – 141123895 C 0.02308 0.1571 T 15.72 7.34E–05 0.1267 8.82E–05 476000 –
5 rs1553239 – 30841081 T 0.2077 0.06786 C 17.43 2.98E–05 3.601 5.78E–05 726273 –
5 rs17592250 LOC101929380 86526909 T 0.09231 0.01071 C 16.77 4.22E–05 9.39 8.43E–05 498501 –
10 rs17731 KLF6 3811561 A 0.4846 0.2464 G 23.07 1.56E–06 2.875 2.00E–06 1000000 Passed
18 rs17804058 CD226 65755221 G 0.1615 0.03929 C 18.44 1.75E–05 4.711 8.72E–05 481518 –
14 rs1862127 ADCK1 77477049 T 0.3385 0.15 C 19.02 1.29E–05 2.899 2.00E–06 1000000 Passed
14 rs2105269 GALNT16 68816987 T 0.6385 0.4214 C 16.73 4.30E–05 2.424 6.67E–05 629370 –
1 rs213490 SSBP3 54627572 T 0.5769 0.35 C 18.74 1.50E–05 2.532 1.90E–05 1000000 Passed
20 rs2327233 – 9808517 C 0.5462 0.3393 T 15.77 7.16E–05 2.343 5.45E–05 771000 –
20 rs2876175 – 9820828 C 0.3462 0.5607 T 16.35 5.26E–05 0.4148 4.21E–05 998000 –
4 rs2939743 C4orf19 37219957 A 0.2462 0.4964 G 22.87 1.73E–06 0.3312 5.00E–06 1000000 Passed
12 rs3751176 – 127241860 A 0.1846 0.3821 G 15.93 6.57E–05 0.3661 7.84E–05 536000 –
14 rs4020132 – 77481947 A 0.3385 0.15 G 19.02 1.29E–05 2.899 2.00E–06 1000000 Passed
4 rs4107575 C4orf19 37238678 A 0.2769 0.4893 G 16.42 5.09E–05 0.3998 0.0001007 417000 –
14 rs4903671 – 77481783 A 0.3231 0.1357 C 19.84 8.40E–06 3.039 6.00E–06 1000000 Passed
22 rs5765425 FBLN1 44271097 A 0.3462 0.5607 G 16.35 5.26E–05 0.4148 4.82E–05 872127 –
20 rs6039614 – 9815136 C 0.3462 0.5643 A 16.9 3.94E–05 0.4088 3.30E–05 1000000 Passed
20 rs6071392 – 58880119 T 0.3231 0.15 C 16.33 5.33E–05 2.705 4.21E–05 998000 –
20 rs6118782 – 9811911 C 0.3538 0.5679 T 16.26 5.51E–05 0.4167 5.02E–05 837162 –
1 rs6688707 – 100040996 T 0.2846 0.5107 G 18.43 1.76E–05 0.3812 1.70E–05 1000000 Passed
2 rs6733573 – 204840871 T 0.3308 0.1536 C 16.82 4.12E–05 2.724 5.29E–05 794000 –
3 rs6770415 – 13242771 G 0.3231 0.1429 A 18.02 2.18E–05 2.864 7.16E–05 587000 –
3 rs7616568 – 2045846 G 0.3385 0.5643 A 18.11 2.08E–05 0.3951 1.20E–05 1000000 Passed
8 rs7845105 TRAPPC9 140978153 T 0.06154 0 G 17.57 2.76E–05 NA 6.90E–05 609000 –
15 rs8026848 FAM189A1 27361149 C 0.2231 0.07857 G 17.02 3.70E–05 3.367 5.58E–05 753000 –
19 rs8103262 ZNF808,ZNF701 57757626 C 0.3 0.125 T 18.38 1.81E–05 3 3.30E–05 1000000 Passed
6 rs9466669 – 23297836 A 0.06154 0 G 17.57 2.76E–05 NA 8.16E–05 514485 –
3 rs9815240 PLSCR4 147394867 C 0.1538 0.03214 A 20.01 7.72E–06 5.475 1.70E–05 1000000 Passed
2 rs986846 – 239172751 T 0.3 0.5143 C 16.5 4.87E–05 0.4048 2.40E–05 1000000 Passed
Table 1.  Empirical and theoretical distribution of the associated markers (p-value ≤1 × 10−5) of Vvs. 
PK, Pvs.VK and Kvs.VP.
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permutation while rs10197747 having p-value 2.50 × 10−5 achieved 106 permutations, which of course 
revealed that rs2939743 is false positive. Similarly, we found 52 true positive SNPs achieved 1 million 
simulations with theoretical p-value ≤ 1 × 10−5 (details are given in Table 1; Figure S6).
It is well known that some markers differ in allele frequency more across ancestral population, com-
pared to other set of markers. Moreover, natural selection might be the reason for this phenomenon 
because it acts locus-specific manner21. We speculate that the above so-called true positive loci might be 
artifacts of population stratification because of high probability of false positive results at the p-value, 
which observed in association analysis. Hence, we performed extensive statistical analyses to control these 
confounding factors and/or population stratification. Prevailing methods include genomic control and 
EIGENSTRAT to find such confounding effect of stratification. Genomic control uses uniform inflation 
factor to correct stratification, which is not sufficient for those SNPs having high frequency differences 
between ancestors21. Hence, we proceeded with EIGENSTRAT and found p-value did not change dras-
tically (Table S9). To further confirm, we used variance component model (implemented in EMMAX)27 
and mixed-linear model of association analysis (implemented in GCTA)28, which can correct sample 
structure in association, but have different statistics comparative to eigenstrat. Intriguingly, even with 
this analysis, we did not observe any drastic change in the p-value (Table S9). This has proved that these 
52 SNPs were genuine characteristics of Prakriti and not derived from ancestry. Moreover, we also explored 
the allele frequency differences between centers; however, we did not find any significant difference for 
these 52 SNPs (Table S10). We further explored the power of 52 SNPs in Prakritis genetic differentiation 
(Figure S1). In principal component analysis, 19 SNPs were excluded with r2 > 0.75 and, as expected, 
we found striking separation of subjects according to their Prakriti (Fig. 2A). On eigenvector-1 (eigen-
value = 18.168248) Pitta significantly differentiated against Vata and Kapha (p-value = 1.11022 × 10−16, 
4.44089 × 10−16, respectively); while on eigenvector 2 (eigenvalue = 15.890861) Kapha was significantly 
different compared to Vata and Pitta (p-value = 3.33067 × 10−16 and ~0 respectively).
To examine the statistical power of these 52 markers for categorizing the samples with unknown 
Prakriti, we generated a statistical model (see methods). Initially, we applied it on 205 samples and found 
23.9% (49 out of 205) were explained by the proposed model (Table S11). Further, we applied it on 297 
Indian (population) samples and found 37 individuals (5 Austro-Asiatic; 22 Dravidian; 8 Indo-European 
and 2 Tibeto-Burman) satisfying the model. According to the model, 7 individuals were Vata, 20 were 
Pitta and 11 were Kapha. Interestingly, Indian population samples, which belong to one Prakriti were 
from different ancestry (Table S12), suggesting that these makers could separate the Prakritis, irrespec-
tive of their ancestry. To confirm the proposed model, we projected these 37 individuals on eigenvector 
of Prakriti samples and found that these individuals clustered with Prakriti as predicted in the model 
(Fig.  2B). It suggests that the cluster is based on Prakriti, and is not due to the ancestry of samples. 
That would also suggest that the phenotypic variations have a genetic basis, which would be shared by 
Prakritis of Ayurveda.
Further, we used these 52 markers to find the genotype-phenotype correlations. We observed that 2 
markers (rs10518915 and rs986846) were associated with two different Prakriti; rs10518915 with Vata 
and Pitta, while rs986846 with Kapha and Vata. This observation prompted us to believe that different 
alleles of the same locus might be influencing different Prakriti (Table 1). In order to correlate the func-
tional relevance of these SNPs, we divided them into genic and non-genic. The SNPs, which are within 
10 kb of gene, were considered genic; while others as non-genic29,30. We found 28 were genic SNPs, of 
which 12 were in Vata (7 genes), 11 in Pitta (7 genes), and 6 in Kapha (7 genes) (Table 1). To correlate the 
Figure 2. Principal component analysis (PCA) with 52 SNPs that showed p-value of <1 × 10-5 (A) PCA 
of Prakriti individuals showing three clusters (Vata, Pitta, Kapha), despite their linguistic, ethnic and 
geographical diversity. (B) PCA projection of Indian population samples with Prakriti individuals.
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function of these genes with respect to the characteristics of Prakritis, we searched in Kyoto Encyclopedia 
of Genes and Genomes (KEGG) pathway and Reactome event and found PGM1 gene associated with the 
Pitta phenotype. In Ayurveda, characteristics of Pitta include digestion, metabolism and energy produc-
tion. Interestingly, we found PGM1 gene is in the center of many metabolic pathways i.e. glycolysis or 
gluconeogenesis (hsa00010); pentose phosphate pathway (hsa00030); galactose metabolism (hsa00052); 
purine metabolism (hsa00230) and; starch and sucrose metabolism (hsa00500) (Figure S7). Our finding 
suggests that the function of the gene directly correlates with the role of Pitta in metabolism as described 
in Ayurvedic literature.
In addition, we have checked the PGM1 gene markers in Affymetrix data set and found 4 mark-
ers (rs2269241, rs2269240, rs2269239,and rs2269238) were associated with Pitta Prakriti and all are in 
strong Linkage Disequilibrium (LD) (Figure S8). Therefore, to find the functionally relevant variants, we 
sequenced the whole exons and UTRs of the PGM1 gene in 78 individuals using Ion Torrent PGM (Life 
Technologies, USA). We found 23 variations in the gene, of which 8 were novel (Table S13). Interestingly, 
one non-synonymous; c.1258T > C (p.Tyr420His) (rs11208257) variant was present in the LD block and 
found in association with Pitta Prakriti (p-value–7.049 × 10−3). The frequency of the mutant allele “C” 
was 5.8% in Pitta and 20% in Kapha Prakriti (Table S14). This result prompted us to replicate the marker 
(rs11208257) in additional samples. We genotyped this marker (rs11208257) for 665 Prakriti individ-
uals (299 Vata, 164 Pitta and 202 Kapha) using Sanger sequencing method. Initially, we analyzed the 
distribution of the genotype among participating centres and found “U” samples (collected from Udupi 
centre) were not in HWE (p-value - 0.04) (Table S15). Hence, we excluded 169 “U” samples from the 
analysis. Association analysis revealed that allelic and genotype distribution of the marker rs11208257 
is significantly different in Pitta Prakriti against Vata and Kapha with p-value- 2.06 × 10−2; p-value- 
6.16 × 10−3, respectively. Further, we explored the association between P vs. V and P vs. K; and found 
significant p-value - 7.61 × 10−3 and 2.35 × 10−2, respectively. The results would therefore suggest that 
Vata differs more from the Pitta Prakriti than Kapha (Table S16). We further screened 1108 randomly 
selected Indians and 992 HapMap samples and found that the frequency of mutant allele “C” was 17.9% 
among Indians, 15.5–17.6% in the Europeans, 14.5–18.8% in East Asians, 42% in Mexican, 15.3% in 
admixed Indians (GIH) and 12.8–28.3% in Africans. Indians have comparable frequency with Europeans 
and GIH (Table S17). Interestingly, we found Pitta has less frequency of mutant “C” allele, and Vata and 
Kapha have comparable frequency with overall Indian population. To explore the functional relevance 
of the variant, we used SIFT software and found that the mutation is damaging with 0.01 score and thus 
substitution at this position may affect the protein function. Our data suggest that the SNP (rs11208257) 
in PGM1 gene is linked with one of the main features (energy production), which is more homogenous 
and constant in Pitta than with Vata and Kapha, and a genotype correlation exists for the characteristics 
of Prakriti classification.
In conclusion, our preliminary study suggests that the Prakriti classification, as a foundation for the 
practice of Ayurveda, has a genetic basis and does provide clues for further studies.
Methods
Selection of subjects and Prakriti assessment. Selection of subjects and evaluation of the Prakriti 
(the human classification of Indian ancient medicine) were carried out at three centres; 1. Institute of 
Ayurveda and Intergrative Medicine (IAIM), Bangalore, Karnataka; 2. Sinhgad College of Engineering 
(SCE) Pune, Maharashtra; and 3. Shri Dharmasthala Manjunatheshwara College of Ayurveda (SDMCA) 
Udupi, Karnataka. This study was approved by Institutional Ethics Committees (IECs) of all the collab-
orative centres and the methods were carried out in accordance with the approved guidelines. We have 
screened normal and healthy male subjects, who were between 20–30 years. Although several Ayurveda-
based studies have included both male and female subjects7,8,15,16, we have excluded female subjects from 
this study to minimize the confounding variations. Prakriti of an individual is determined based on 
defined anatomical, physiological psychological and behavioural characteristics. During actual assess-
ment of Prakriti, the Ayurvedic physician needs to factor in these characteristics. One such aspect is the 
cyclical hormonal changes that occur in women, particularly the menstrual cycle. The hormonal fluc-
tuations result in numerous physical and psychological disturbances, which occur in the premenstrual 
and menstrual phases. Existing evidence suggest that about 97% of young nulliparous women experience 
varying degrees of such disturbances31. These elicitable and visible features can confound or obscure 
the Prakriti assessment process. For example, premenstrual irritability occurring in a woman of Kapha 
Prakriti is confounding, since Kapha Prakriti individuals normally possess low irritability. Although the 
Ayurvedic physicians routinely enquire about the menstrual habits of patients while assessing the Prakriti, 
it would have been difficult for us to make similar enquiries to young, healthy women who volunteered 
to join this study. The health status of an individual was assessed based on the Ayurvedic criteria, that 
include; normal desire for food, easy digestion of ingested food, excretion of feces, excretion of urine, 
excretion of flatus, functioning of sensory organs, comfortable sleep, easy awakening, and attainment of 
strength, bright complexion and longevity. Subjects with smoking habit, diabetes, hypertension and other 
chronic diseases were excluded from the study. Blood pressure (BP) was measured for each subject and 
BP > 130/90 mm of Hg were excluded from the study. Chronic systemic diseases such as rheumatoid 
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arthritis, cancer, etc., and subjects having recent history of acute ailments such as fever due to infections 
were also excluded.
We followed three steps for the Prakriti assessment of each subjects. In the first stage, senior Ayurvedic 
physicians assessed the Prakriti of the subjects, applying classical Ayurveda parameters of Prakriti deter-
mination. In second stage, the same subjects were assessed using Ayusoft, a Prakriti software (www.
ayusoft.cdac.in), which contains a comprehensive questionnaire, which had been developed based on the 
information from original Ayurvedic literature. In the third stage, another team of Ayurvedic physicians, 
who were not aware of the outcomes of assessment by senior physicians and Ayusoft, compared the 
Prakritis analysis. Subjects with ≥ 60% of single Prakriti dominance and having concordance in all the 
three stages were selected for the genome-wide analysis. Quantitative analysis of Prakriti was performed 
using Ayusoft along with traditional ayurvedic measures for the Prakriti assessment. The reason for 
considering ≥ 60% of a particular Prakritias a dominant was mainly due to feasibility and concordance. 
Single dosha Prakriti with high percentage of one dosha rarely exist, hence most of the individuals pos-
sess dual-dosha Prakriti12. Therefore, we have considered subjects with ≥ 60% as single dosha dominant-
Prakriti. Subjects ≥ 60% of one dominant Prakriti were selected and blood was drawn after obtaining 
their informed written consent. A total of 3,416 healthy individuals were screened for their Prakriti, as 
per the details given above. From the total, 971 subjects who showed a predominant Prakriti of ≥ 60% 
were included in the analysis (Figure S1).
High throughput genotyping, their quality control criteria and resequencing. Genotyping. 
DNA was isolated from the blood samples using standard protocol32. We randomly selected 262 Prakriti 
individuals for genotyping, using Genome-Wide Human SNP Array from Affymetrix (6.0), following 
manufacturer’s protocols. About 250 ng of genomic DNA was digested with Nsp I and Sty I restriction 
enzymes, followed by ligation of Nsp/Styadaptors, using T4 DNA ligase. PCR was performed using the 
primers that are specific to these adopters. After checking the amplicons on 2% agarose gel, they were 
purified with deep-well plate using magnetic beads and the fragments were eluted using EB buffer, fol-
lowed by quantification and fragmentation. The fragmented PCR products (< 180 bp) were end-labeled 
using labeling kit. Labeled fragments were hybridized onto the Affymetrix (6.0) SNP arrays using hybrid-
ization cocktail. Hybridization was performed in hybridization oven for about 18 hrs at 50 °C. After 
hybridization, arrays were washed, stained, scanned and analyzed using Affymetrix Genotyping Console 
2.0 and GeneChip® Operating Software (GCOS). The samples which passed the quality controls i.e. call 
rate > 95% and CQC > 0.4 were considered. Affymetrix power tool (apt-geno-qc) was used for calcu-
lation of dm (dynamic model) value. The samples having dm.all_qc< 0.83 were removed from further 
analysis and genotypes were fetched with Birdsuite software from Broad Institute17 (Figure S1).
Detection of technical artifacts. In order to validate the Affymetrix data set, we randomly selected 48 
markers (Table S3) from Affymetrix array and genotyped 48 individuals, who were already genotyped 
by Affymetrix array, using custom-designed VeraCode GoldenGate Genotyping Assay System (Illumina, 
San Diego, USA). Genotyping was performed according to the manufacturer’s (Illumina, San Diego, 
USA) instructions. The genotypes obtained by both the platforms were compared and checked for accu-
racy (Figure S1).
Targeted resequencing. We sequenced the whole-exons and UTRs of PGM1 gene (Figure S1) for ran-
domly selected 43 Pitta and 35 Kapha individuals using Ion Torrent (Life Technologies, USA), follow-
ing protocols of the manufacturer. Primer sequences were manufactured specifically for use with Ion 
AmpliSeq kits. The costume Ion AmpliSeqTM primer contains 35 amplicons in a single pool. For pre-
paring amplicon libraries, about 10 ng of DNA was amplified (PCR) using AmpliSeqTM primer pools 
and Ion AmpliSeqTM HiFi master mix (Ion AmpliSeq kit version 2.0 Beta). The amplified products were 
pooled and treated with 2 μ l of FuPa reagent. The amplicons were then ligated with adapters from the Ion 
XpressTM barcoded adapters 17–64 kit according to the manufacturer’s instructions (Ion Torrent). After 
ligation, the amplicons were purified by Agencourt® AMPure® XP Reagent and additional amplification 
was performed to complete linkage between adapters and amplicons. In order to determine the library 
concentration, an Agilent 2100 Bioanalyzer high-sensitivity DNA kit (Agilent, Santa Clara, CA) was used 
to visualize the size range of the libraries. Equimolar concentrations of all the libraries were pooled and 
diluted. Using Ion One TouchTM 200 Template Kit v@ DL (Life Technologies, USA), emulsion PCR was 
carried out according to the manufacturer’s instructions. Ion Spheres (ISPs) were recovered according 
to the Ion Sphere Particles 200 recovery protocol. Sequencing was done following the Ion PGMTM 200 
Sequencing Kit Protocol (version 6; Ion Torrent). The 318 sequencing chip was loaded and run on an 
Ion Torrent PGM (Ion Torrent). Base calling and alignment were performed using the Torrent Suite 3.0 
software (Ion Torrent). In order to find the significant variation in the PGM1 whole exome data, we per-
formed association analysis using plink software26 and variations are annotated on EnsEMBL-BioMart.
Sanger sequencing. To validate and replicate the Pitta associated SNP (rs11208257), Sanger sequenc-
ing was carried out for 496 Prakriti samples (246 Vata, 116 Pitta and 134 Kapha) along with randomly 
selected 1108 Indian samples. Pair of primers (Forward primer: 5′ - GCACGTTTCTTACAGCAGCT-3′ 
and Reverse primer: 5′ -ACCTTACCTTGTACCCCAGC-3′ ) were designed, synthesized and PCR was 
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performed on the GeneAmp 9700 Thermal Cycler (Applied Biosystems, Perkin-Elmer) using the fol-
lowing cycling conditions: 95 °C for 5 min, 35 cycles at 95 °C for 30 s, 58 °C for 30 s, 72 °C for 2 min and 
a final extension at 72 °C for 7 min. Amplicons were purified using with USB ExoSAP-IT (Affymetrix) 
according to the manufacturers instructions. The purified products were directly sequenced using the 
Big Dye Terminator cycle sequencing kit (Applied Biosystems, Foster City, CA, USA) and analyzed using 
3730 DNA Analyzer (Applied Biosystems, Foster City, CA, USA)(Figure S1). The genotypes were noted, 
and statistical analysis was performed with plink26 and R.
Indian, HapMap and 1000 genome project sample details. For comparative analysis, we 
used Affymetrix (6.0) array data of 297 well-classified Indian samples with known lingustic and eth-
nic affiliations i.e. 150 Dravidians, 80 Indo-European, 35 Austro-Asiatic, 27 Tibeto-Burman and 5 
Great Andamanese. In addition, 15 trios of Dravidian (Vysya, Madiga, Mala; 5 each) and 15 trios of 
Indo-European (Kshatriya, Brahmin and Kashmiri Pandit; 5 each) were used for imputation19,20. We 
followed the same procedure (mentioned above) for extraction of genotypes and CQC measures. The 
list of population and their details are given in Table S6. We have also used 1184 HapMap (ftp://ftp.ncbi.
nlm.nih.gov/hapmap/genotypes/2009-01_phaseIII/plink_format/) and 1000 genome project data (ftp://
ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20130502/) for imputation and comparative analysis.
Imputation and their relationship with ancestry. Imputation was performed for the missing gen-
otypes using Beagle-v3.3.2 software18. In order to check the power of correct imputation, we randomly 
masked 2%, 5% and 10% genotype of chromosome 22 in 207 unrelated Indian population samples. We 
imputed masked genotypes with four types of reference i.e. Indian triose (15 trios of Dravidian and 15 
trios of Indo-European), HapMap samples (CEU, YRI, CHB, CHS and JPT), Indian + HapMap sam-
ples and samples of 1000 genome project with South-Asian ancestry (BEB, GIH, ITU, PJL and STU). 
Accuracy of imputation was calculated by comparing imputed and true genotype in 110 simulations for 
2%, 5% and 10% masked data. To perform the above analysis, we used a perl script.
To impute missing genotype in Prakriti samples, we followed two steps; In the first step, imputa-
tion and phasing was done for 15 trios of Dravidian (Vysya, Madiga, Mala; 5 trios each) and 15 trios 
of Indo-European (Kshatriya, Brahmin and Kashmiri Pandit; 5 trios each) together without reference 
population. SNPs which do not follow Mendelian rule in trios were checked and masked with Beagle 
utility program18. Number of SNPs per family, which do not follow Mendelian consistency are given 
in Table S5. In the second step, we performed imputation of unrelated population samples (Dravidian, 
Indo-European and Austro-Asiatic), with imputed familial (trios) samples as reference. Further, we 
imputed Prakriti samples with reference of imputed trios and unrelated Indian population samples and 
selected only those markers which were having R2 > 0.95 for further analysis.
Population stratification. Principal component analysis was done with Eigensoft Package21. Convertf 
was used for converting plink ped file to Eigenstrat format. We pruned the SNPs on the basis of their 
Linkage Disequilibrium (r2 > 0.75) before running PCA by using Eigensoft’s killr2 option. Ten eigenvec-
tors were fetched. To find the ancestry of 245 Prakriti samples, we used 297 known ancestry of Indian 
population dataset (previously published) and performed the PCA. Stratification was checked and 40 
outlier samples were excluded with cutoff sigma value ≥ 0.6 (default value) on 1–10 eigenvectors in 10 
iterations (Figure S1).
Association analysis. Plink was used for association analysis26. Imputed Beagle file were converted 
into plink ped file. Association analysis was performed for the Prakritis. Since there are no case control 
groups in the present study, we compared one Prakriti against the other two Prakritis (Vata vs. Pitta and 
Kapha, Pitta vs. Vata and Kapha, and Kapha vs. Vata and Pitta) and calculated p-value from theoretical 
distribution. In order to exclude the markers, which could be in association by chance, we also performed 
adaptive permutation approach (empirical distribution) for maximum 106 iteration withplink and con-
sidered only those markers who achieved maximum 106 permutations and have p-value ≤ 1 × 10−5 in 
theoretical distribution (Figure S1).
Addressing issue of population stratification as possible confounder in association analy-
sis. Even subtle stratification can cause spurious association; hence we used EIGENSTRAT software21 
for correcting association chi-square value on 10 eigenvector and to find its confounding effect. Initially 
we excluded 385, 404 SNPs with r2 > 0.75 and calculated eigenvector with remaining 405, 782 SNPs 
with SMARTPCA. Further we used these same 10 eigenvector for correction of chi-square value with 
EIGENSTRAT (Figure S1).
To address this issue, we also used EMMAX and GCTA tools27,28. Both statistical methods consider 
genetic structure in association analysis. Hence, we expected major changes in p-value of 52 SNPs. First, 
we generated IBS matrix implemented in EMMAX and then used it with 10 eigenvector (generated 
with SMARTPCA) as covariate to calculate p-value with variance component model (implemented in 
EMMAX). To calculate mixed-model association p-value (implemented in GCTA), first, we calculated 
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genetic relationship matrix and 10 eigenvectors with GCTA; and used it in calculation of p-value (Figure 
S1).
Statistical determination of Prakriti in subjects. In order to prove the power of these markers in 
samples of unknown Prakriti percentage, we generated a statistical model (Figure S1). First, this model 
applied to 205 Ayur samples and then replicated in Indian population data set with unknown Prakriti. 
For this, we calculated the weight for the genotype of each marker associated with the Prakriti. Suppose, 
if the frequency of genotype g in Prakriti p is fp then the weight of g(Wgp) can be calculated with equa-
tion (1)
=
∑ ( )
W
f
f 1
gp
p
p
p1
Un-standardized total weight of the Prakriti Wvs for a sample s with n number of associated markers for 
p Prakriti can be calculated using equation (2)
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Hence, for a single sample there will be 3 weights Wvs, Wps and Wks corresponding to Vata, Pitta and 
Kapha using equation (2). For making weights comparable, we standardized by subtracting with mean 
and dividing it by standard deviation. Mean and standard deviation were calculated from total weight 
of each sample for each markers corresponding to each Prakriti. If total number of sample is N then 
standardized weight can be calculated using equation (3)
σ
. =
−
( )
std w
w w
3
ps
ps pN
w pn
Prakriti is relative proposition (tridosha), so we calculated the differences of standardized weight for all 6 
permutations; Δ VP, Δ VK, Δ PV, Δ PK, Δ KP and Δ KP for each samples and calculated representative statistics 
Rp. For example, representative statistics for Kapha Rk can be calculated using equation (4)
= ∆ + ∆ ( )R 4k KP KV
2 2
Since multiplication of 2 negative values is positive, the Rp value could be positive for 2 negative Δ 
values. Hence, we considered only those Rp values, which have both Δ value positive. Moreover, we con-
sider only those samples which have Rp ≥ 3 to find dominant Prakriti. We applied this model to Indian 
population and selected 37 samples on the basis of Rp and Δ values.
Phenotype and genotype correlation. We considered markers within 10 kb flanking region of gene 
as genic and other as non-genic. Physical location of the genes (knownGene.txt.gz) and SNPs (snp135.txt.
gz) were fetched from http://hgdownload.soe.ucsc.edu/goldenPath/hg19/database/ and; windowbed(Bed-
tools: https://code.google.com/p/bedtools/) was used to find the SNPs within 10 kb flanking region of the 
genes. Only genic markers were used for genotype-phenotype correlation. Genic SNPs were selected and 
considered for further analysis. To correlate the function of associated markers with characteristics of 
the individual Prakriti, we checked in KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway and 
Reactome event using NCBI2R R package.We used SIFT algorithm (http://sift.jcvi.org)for predicting the 
effects of non-synonomous variant (rs11208257) on protein function.
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